pharmaphorum media limited

@UCBusIfteFlmaRnIpbMnP6Vg - 936 subscribers

pharmaphorum uses content to connect the pharmaceutical industry and other innovators to advance healthcare. We are publishers, consultants and creatives bringing healthcare together.

Home Videos Live Playlists

CAMP4 on a new class of ASO in gene under expression

CAMP4 on a new class of ASO in gene under expression pharmaphorum media limited

21 hours ago

ASCO 2026: Astellas innovates in ADCs and T Cell engagers, with Tony Jarkowski

ASCO 2026: Astellas innovates in ADCs and T Cell engagers, with Tony Jarkowski pharmaphorum media limited

32 views - 4 days ago

BonelliErede on M&A in Europe: Andrea Carta Mantiglia

BonelliErede on M&A in Europe: Andrea Carta Mantiglia pharmaphorum media limited

6 views - 1 week ago

ASCO 2026: Pluvicto shows consistency, with Dr Fred Saad

ASCO 2026: Pluvicto shows consistency, with Dr Fred Saad pharmaphorum media limited

27 views - 1 week ago

ASCO 2026: All about DNA damage response, with Debiopharm's Luke Piggot

ASCO 2026: All about DNA damage response, with Debiopharm's Luke Piggot pharmaphorum media limited

8 views - 1 week ago

ASCO 2026: Time is tissue: A promising treatment in AL amyloidosis, with Dr Hans Lee

ASCO 2026: Time is tissue: A promising treatment in AL amyloidosis, with Dr Hans Lee pharmaphorum media limited

125 views - 1 week ago

Purespring on nephrology & gene therapy in kidney disease

Purespring on nephrology & gene therapy in kidney disease pharmaphorum media limited

6 views - 2 weeks ago

The evolving role of GLP-1s in oncology research, with Dr Jess Paulus

The evolving role of GLP-1s in oncology research, with Dr Jess Paulus pharmaphorum media limited

17 views - 2 weeks ago

Parexel: Flawless execution, policy shifts & patient-centric design

Parexel: Flawless execution, policy shifts & patient-centric design pharmaphorum media limited

6 views - 3 weeks ago

ASCO 2026: Three ADC approvals in five days, with Ken Keller and John Tsai

ASCO 2026: Three ADC approvals in five days, with Ken Keller and John Tsai pharmaphorum media limited

41 views - 3 weeks ago

ASCO 2026: Can a blood test spot cancer early? with Dr Peter Sasieni

ASCO 2026: Can a blood test spot cancer early? with Dr Peter Sasieni pharmaphorum media limited

37 views - 3 weeks ago

ASCO 2026: A potential functional cure in endometrial cancer, with Eric Richards

ASCO 2026: A potential functional cure in endometrial cancer, with Eric Richards pharmaphorum media limited

39 views - 3 weeks ago

Citius’ Leonard Mazur talks targeted immune therapy for CTCL

Citius’ Leonard Mazur talks targeted immune therapy for CTCL pharmaphorum media limited

42 views - 4 weeks ago

ASCO 2026: Could ADCs finally replace chemotherapy? With AbbVie’s Pedro Valencia

ASCO 2026: Could ADCs finally replace chemotherapy? With AbbVie’s Pedro Valencia pharmaphorum media limited

75 views - 1 month ago

Radiopharma in 2026 & beyond, with ITM's Dr Andrew Cavey

Radiopharma in 2026 & beyond, with ITM's Dr Andrew Cavey pharmaphorum media limited

45 views - 1 month ago

ASCO 2026: Can your microbiome effect your response to cancer treatment? with Dr Rahul Winayak

ASCO 2026: Can your microbiome effect your response to cancer treatment? with Dr Rahul Winayak pharmaphorum media limited

45 views - 1 month ago

ASCO 2026: Quality of life, not just quantity, with Dr Harold Keer

ASCO 2026: Quality of life, not just quantity, with Dr Harold Keer pharmaphorum media limited

55 views - 1 month ago

ASCO 2026: Takeda’s Innovent deal bears fruit, with Teresa Bitetti and PK Morrow

ASCO 2026: Takeda’s Innovent deal bears fruit, with Teresa Bitetti and PK Morrow pharmaphorum media limited

64 views - 1 month ago

Biosimilars & patient access independent of geographies or socioeconomics, with Rebecca Guntern

Biosimilars & patient access independent of geographies or socioeconomics, with Rebecca Guntern pharmaphorum media limited

7 views - 1 month ago

ASCO 2026: First to first line in HER-2 NSCLC, with Itziar Canamasas

ASCO 2026: First to first line in HER-2 NSCLC, with Itziar Canamasas pharmaphorum media limited

41 views - 1 month ago

ASCO 2026: Chinese firms take a front seat in oncology, with Li Mao and Giovanni Selvaggi

ASCO 2026: Chinese firms take a front seat in oncology, with Li Mao and Giovanni Selvaggi pharmaphorum media limited

43 views - 1 month ago

ASCO 2026: Precision medicine takes a village, with Carolyn Sousa and Henar Hevia

ASCO 2026: Precision medicine takes a village, with Carolyn Sousa and Henar Hevia pharmaphorum media limited

87 views - 1 month ago

Towards a healthier world: Momentum in UK health system transformation, with Lee-Ann Farrell

Towards a healthier world: Momentum in UK health system transformation, with Lee-Ann Farrell pharmaphorum media limited

12 views - 1 month ago

ASCO: Three strong Pfizer Phase 3s, with Johanna Bendell

ASCO: Three strong Pfizer Phase 3s, with Johanna Bendell pharmaphorum media limited

92 views - 1 month ago

ASCO26: Agentic AI supercharging genome sequencing for early cancer detection, with David Spetzler

ASCO26: Agentic AI supercharging genome sequencing for early cancer detection, with David Spetzler pharmaphorum media limited

383 views - 1 month ago

IQVIA on reducing complexity and workload for clinical trial sites

IQVIA on reducing complexity and workload for clinical trial sites pharmaphorum media limited

5K views - 1 month ago

Trustworthy and novel AI in clinical trial planning, with Kris Kaneta

Trustworthy and novel AI in clinical trial planning, with Kris Kaneta pharmaphorum media limited

43 views - 1 month ago

Rethinking clinical research: The case for human challenge trials

Rethinking clinical research: The case for human challenge trials pharmaphorum media limited

4.8K views - 2 months ago

The cardio-renal-metabolic space and obesity as a chronic disease, with Ramy Younes

The cardio-renal-metabolic space and obesity as a chronic disease, with Ramy Younes pharmaphorum media limited

17 views - 2 months ago

From data to deployment: Navigating AI adoption in pharma with Veeva

From data to deployment: Navigating AI adoption in pharma with Veeva pharmaphorum media limited

42 views - 2 months ago

On the power of T-cells, with Cedrik Britten

On the power of T-cells, with Cedrik Britten pharmaphorum media limited

17 views - 2 months ago

Why everyone should care about longevity, with Boyang Wang

Why everyone should care about longevity, with Boyang Wang pharmaphorum media limited

14 views - 2 months ago

A philosophical look at market turn in the Age of AI, with John Holodnak

A philosophical look at market turn in the Age of AI, with John Holodnak pharmaphorum media limited

29 views - 2 months ago

Providing patient access to new therapies, with Dean Erhardt

Providing patient access to new therapies, with Dean Erhardt pharmaphorum media limited

11 views - 2 months ago

LSX2026: Endogenous tissue restoration in vascular disease – Insights from Paulo Neves

LSX2026: Endogenous tissue restoration in vascular disease – Insights from Paulo Neves pharmaphorum media limited

30 views - 3 months ago

Pushing through barriers to commercial launch success, with Amanjeet Singh Saluja

Pushing through barriers to commercial launch success, with Amanjeet Singh Saluja pharmaphorum media limited

9 views - 3 months ago

Every drug is a story, with Thomas Goetz

Every drug is a story, with Thomas Goetz pharmaphorum media limited

17 views - 3 months ago

LSX2026: Non-opioid pain relief and pharma positivity, with Mike Cooke

LSX2026: Non-opioid pain relief and pharma positivity, with Mike Cooke pharmaphorum media limited

26 views - 3 months ago

LSX2026: Addressing adult eye cancer, with Roi Raz

LSX2026: Addressing adult eye cancer, with Roi Raz pharmaphorum media limited

23 views - 3 months ago

Making direct-to-patient work, with Matt Wadyka

Making direct-to-patient work, with Matt Wadyka pharmaphorum media limited

46 views - 3 months ago

Looking to gene therapy for ocular diseases, with Lance Baldo

Looking to gene therapy for ocular diseases, with Lance Baldo pharmaphorum media limited

18 views - 3 months ago

Biotech is back, with Craig Ackerman

Biotech is back, with Craig Ackerman pharmaphorum media limited

43 views - 3 months ago

LSX2026: On a therapeutic vision for ocular disease, with Alexander Gebauer

LSX2026: On a therapeutic vision for ocular disease, with Alexander Gebauer pharmaphorum media limited

22 views - 3 months ago

LSX2026: On promise and patience, with Hans Schambye

LSX2026: On promise and patience, with Hans Schambye pharmaphorum media limited

30 views - 3 months ago

Creating what nature has not from AI and computational molecular biophysics with Kashif Sadiq

Creating what nature has not from AI and computational molecular biophysics with Kashif Sadiq pharmaphorum media limited

15 views - 3 months ago

BIO-Europe Spring 2026: In conversation with Marjorie Sidhoum

BIO-Europe Spring 2026: In conversation with Marjorie Sidhoum pharmaphorum media limited

119 views - 3 months ago

Hernexeos and what’s next, with Vicky Brown

Hernexeos and what’s next, with Vicky Brown pharmaphorum media limited

71 views - 3 months ago

On collaboration, computational chemistry, and cutting-edge AI – with Olga Nissan

On collaboration, computational chemistry, and cutting-edge AI – with Olga Nissan pharmaphorum media limited

18 views - 3 months ago

Using patient data to fill in GLP-1 blind spots, with Phil Johnson

Using patient data to fill in GLP-1 blind spots, with Phil Johnson pharmaphorum media limited

22 views - 3 months ago

BIO-Europe Spring 2026: In conversation with Robert Jacks

BIO-Europe Spring 2026: In conversation with Robert Jacks pharmaphorum media limited

61 views - 3 months ago

Making AI work where it matters, with Rob DiCicco

Making AI work where it matters, with Rob DiCicco pharmaphorum media limited

18 views - 4 months ago

Treating genetic disease at scale with tRNA, with Michelle Werner

Treating genetic disease at scale with tRNA, with Michelle Werner pharmaphorum media limited

15 views - 4 months ago

AI in clinical development & ‘white space’, with Andrew Mackinnon

AI in clinical development & ‘white space’, with Andrew Mackinnon pharmaphorum media limited

9 views - 4 months ago

Collaboration & personalisation in rare disease R&D, with AOP Health’s Melissa Fellner

Collaboration & personalisation in rare disease R&D, with AOP Health’s Melissa Fellner pharmaphorum media limited

65K views - 4 months ago

Policy in Focus: Unpacking GLOBE, GUARD, and TrumpRx with Alice Valder Curran

Policy in Focus: Unpacking GLOBE, GUARD, and TrumpRx with Alice Valder Curran pharmaphorum media limited

46 views - 4 months ago

On JPM2026 and healthcare investment today, with Jonah Comstock

On JPM2026 and healthcare investment today, with Jonah Comstock pharmaphorum media limited

36 views - 5 months ago

New hope for ovarian cancer, with Alexander Schneider

New hope for ovarian cancer, with Alexander Schneider pharmaphorum media limited

74 views - 5 months ago

Precision medicine in action, with Cary Claiborne

Precision medicine in action, with Cary Claiborne pharmaphorum media limited

54 views - 5 months ago

On addressing drug waste and ensuring access, with Jeff Harper

On addressing drug waste and ensuring access, with Jeff Harper pharmaphorum media limited

17 views - 5 months ago

Treating the chronic diseases GLP-1s miss, with Laurent Audaly

Treating the chronic diseases GLP-1s miss, with Laurent Audaly pharmaphorum media limited

28 views - 5 months ago